It was mixed with chloroformate in pyridine to form cetilistat, which is a pancreatic lipase inhibitor for the treatment of obesity (Kopelman et al., 2007; Ding et al., 2015). Here, PNLIP is linked to obesity due to melanocortin 4 receptor deficiency.